Hemorrhoids Treatment Market Size, Share & Trends Analysis Report By Treatment Type (Pharmacological Treatments, Minimally Invasive Procedures, Surgical Treatments, Others), By Hemorrhoid Type (Internal Hemorrhoids, External Hemorrhoids, Prolapsed, Thrombosed) and By Region (North America, Europe, APAC, Middle East and Africa, LATAM) Forecasts, 2026-2034

Hemorrhoid Treatment Market Dynamics

Market Drivers

Increasing Use of Anticoagulant Therapies and Growing Focus on Postpartum Hemorrhoid Management Drives Market

The increasing use of anticoagulants and antiplatelet medications among elderly cardiovascular patients is driving demand for low-bleeding-risk hemorrhoid interventions. Conventional hemorrhoidectomy may require medication adjustments, whereas procedures such as Doppler-guided hemorrhoidal artery ligation and sclerotherapy offer less invasive alternatives. As global populations age and long-term anticoagulant use rises, healthcare providers are increasingly adopting treatment approaches designed for this specific patient cohort, supporting hemorrhoid treatment market growth.

The growing emphasis on postpartum hemorrhoid care is a significant market driver for hemorrhoid treatment demand. Hemorrhoids frequently develop during pregnancy and after childbirth due to increased pelvic pressure, hormonal changes, and delivery-related straining. For example, various NHS maternity trusts in the UK expanded postnatal pelvic health services that include assessment and management of anorectal conditions such as hemorrhoids, reflecting greater clinical attention to postpartum recovery. This increased focus on maternal anorectal health is contributing to higher utilization of hemorrhoid medications and minimally invasive treatment procedures.

Market Restraints

Patient Reluctance toward Early Clinical Consultation and Limited Reimbursement for Office-based Hemorrhoid Procedures Restrain Market

Hemorrhoidal symptoms are frequently underreported because patients often delay seeking medical attention due to embarrassment, social stigma, and fear of anorectal examinations. Many individuals initially rely on self-care measures or over-the-counter remedies, postponing professional treatment until symptoms worsen. This delay reduces early intervention rates and limits utilization of prescription therapies and office-based procedures, creating a significant restraint on market expansion.

Various minimally invasive hemorrhoid treatments, including Doppler-guided hemorrhoidal artery ligation and radiofrequency ablation, face inconsistent reimbursement coverage across healthcare systems. Reimbursement disparities increase out-of-pocket expenses and discourage adoption despite favorable clinical outcomes. Many healthcare providers continue using conventional approaches because newer procedural options may not receive equivalent compensation. This reimbursement gap slows technology penetration and restricts broader commercialization of advanced hemorrhoid treatment modalities.

Market Opportunities

Increasing Adoption of AI-assisted Anorectal Imaging and Expansion of Women's Pelvic Health Clinics Offer Growth Opportunities for Hemorrhoid Treatment Market Players

The use of AI-assisted anorectal imaging and diagnostic platforms in colorectal practice is creating a significant growth opportunity. Advanced image-analysis systems help physicians identify hemorrhoidal disease severity more accurately, improving treatment selection and reducing diagnostic variability. For example, AI-enabled endoscopic assessment tools are increasingly used in gastroenterology centers to support earlier detection of anorectal abnormalities. This technological integration is expected to increase procedural volumes and utilization of targeted hemorrhoid treatment solutions.

The rapid growth of specialized women's pelvic health and postpartum recovery clinics is creating opportunities for hemorrhoid treatment providers. These centers increasingly manage pregnancy-related anorectal disorders alongside pelvic floor rehabilitation and maternal wellness services. For example, the UK's NHS Long Term Plan continues expanding Perinatal Pelvic Health Services (PPHS) across England, providing structured postpartum assessment pathways for pelvic and anorectal conditions. The broader integration of postpartum pelvic health care is improving diagnosis rates and increasing referrals for hemorrhoid medications and minimally invasive procedures.

Market Challenges

Lack of Standardized Treatment Selection Pathways and Limited Specialist Availability Challenges Hemorrhoid Treatment Market Growth

Treatment decisions for hemorrhoidal disease often vary significantly between colorectal surgeons, gastroenterologists, and proctologists due to the availability of multiple procedural and pharmacological options. Similar-grade hemorrhoids may receive different treatments across healthcare facilities, creating inconsistency in patient management. This variability complicates technology adoption, limits procedural standardization, and creates challenges for manufacturers seeking broader clinical acceptance of newer hemorrhoid treatment modalities.

Advanced hemorrhoid treatments such as Doppler-guided hemorrhoidal artery ligation, stapled hemorrhoidopexy, and radiofrequency ablation require specialized training and procedural expertise. However, access to experienced colorectal specialists remains uneven across many healthcare systems. This shortage restricts patient access to advanced interventions, prolongs waiting times, and limits the utilization of newer treatment technologies, creating a significant challenge for market expansion and procedural adoption.

Hemorrhoid Treatment Market Segmentation Analysis

By Treatment Type

By treatment type, pharmacological treatment accounted for the largest hemorrhoid treatment market share of 44.73% in 2025 due to its widespread use as the initial treatment option for symptomatic hemorrhoids. Easy availability, lower treatment costs, and increasing use of flavonoid-based therapies and combination topical formulations supported strong adoption across outpatient and home-care settings.

The minimally invasive procedures segment is projected to grow at a CAGR of approximately 6.81% during the forecast period due to increasing preference for treatments that offer reduced postoperative pain, shorter recovery periods, and lower complication rates compared with conventional hemorrhoidectomy. Growing adoption of Doppler-guided hemorrhoidal artery ligation, radiofrequency ablation, and rubber band ligation in outpatient settings is further accelerating segment growth.

By Hemorrhoid Type

Based on hemorrhoid type, the internal hemorrhoids segment is expected to grow at a CAGR of 53.07% during the forecast period due to its suitability for office-based procedures such as rubber band ligation and sclerotherapy. Higher detection during colorectal screening colonoscopies and broader availability of non-surgical treatment options continue to support segment growth.

The prolapsed segment is projected to grow at a CAGR of 7.16% during the forecast period due to increasing diagnosis of Grade III and Grade IV hemorrhoids that require procedural intervention. Greater utilization of stapled hemorrhoidopexy, Doppler-guided dearterialization, and other prolapse-specific treatment techniques drives segment growth.

Hemorrhoid Treatment Regional Outlook

North America Hemorrhoid Treatment Market

North America: Market Dominance Led by High Utilization of Office-based Procedures and Growing Adoption of Minimally Invasive Hemorrhoid Management Practices

The North America hemorrhoid treatment market accounted for the largest regional share of 35.11% in 2025 due to widespread availability of specialized colorectal centers, high utilization of office-based procedures, and strong reimbursement support for anorectal care. The region has witnessed increasing adoption of rubber band ligation, infrared coagulation, and Doppler-guided hemorrhoid treatments. Additionally, extensive colorectal cancer screening programs facilitate early detection of internal hemorrhoids during colonoscopies, increasing treatment volumes and supporting demand for pharmacological and procedural interventions across healthcare settings.

US Hemorrhoid Treatment Market

The US hemorrhoid treatment market was estimated to be USD 355.52 million in 2025, due to presence of specialized colorectal networks, increasing adoption of minimally invasive procedures, and strong outpatient treatment infrastructure. The country benefits from widespread use of ambulatory surgical centers that perform hemorrhoid procedures with reduced hospitalization requirements. For example, USA Hemorrhoid Centers continues expanding awareness and access to non-surgical hemorrhoid treatments through dedicated outpatient facilities. Growing colorectal screening participation and increasing preference for rapid-recovery procedures are further supporting market expansion across the US.

Canada Hemorrhoid Treatment Market

The hemorrhoid treatment market in Canada was valued at USD 53.12 million in 2025, fueled by increasing integration of anorectal care within publicly funded healthcare services, growing awareness of colorectal health, and expanding access to specialist consultations. The country benefits from organized colorectal screening initiatives that contribute to earlier diagnosis of hemorrhoidal disease. In addition, Canadian healthcare providers are increasingly adopting minimally invasive hemorrhoid management approaches to reduce surgical burden and improve patient outcomes. The growing focus on outpatient care pathways is supporting utilization of office-based hemorrhoid treatment procedures countrywide.

Asia Pacific Hemorrhoid Treatment Market

Asia Pacific: Fastest Growth Driven by Increasing Colorectal Disease Awareness and Continuous Healthcare Infrastructure Modernization

The Asia Pacific hemorrhoid treatment market is expected to grow at a CAGR of 8.45% during the forecast period, showcasing the fastest regional growth. This growth is fueled by increasing colorectal disease awareness, expanding endoscopy infrastructure, and rising adoption of minimally invasive hemorrhoid procedures across major healthcare systems. Governments are investing in digestive health screening initiatives, while private hospitals are increasing availability of outpatient anorectal services. Growing urbanization, sedentary lifestyles, and rising incidence of constipation-related disorders are further contributing to increased diagnosis and treatment demand across the region.

China Hemorrhoid Treatment Market

The hemorrhoid treatment market in China, which was estimated to be USD 67.00 million in 2025, is growing due to rapid expansion of specialized colorectal hospitals, increasing utilization of endoscopic examinations, and rising demand for minimally invasive anorectal procedures. The country benefits from continuous healthcare infrastructure modernization and growing access to advanced proctology services in urban centers. Large tertiary hospitals are increasingly adopting Doppler-guided hemorrhoid procedures and stapled hemorrhoidopexy techniques. Additionally, increasing awareness of digestive health and growing participation in colorectal screening programs are supporting earlier diagnosis and treatment uptake.

India Hemorrhoid Treatment Market

The hemorrhoid treatment market in India was valued at USD 34.66 million in 2025, fueled by the country's large burden of constipation and anorectal disorders, increasing adoption of laser proctology procedures, and expansion of organized specialty-care networks. For example, Pristyn Care and Apollo Hospitals have expanded access to laser hemorrhoid treatments across multiple Indian cities, improving availability of minimally invasive care. Additionally, the growing penetration of health insurance coverage and rising utilization of day-care surgical procedures are encouraging patients to seek earlier treatment for hemorrhoidal disease rather than delaying intervention.

Japan Hemorrhoid Treatment Market

The Japan hemorrhoid treatment market was estimated to be USD 45.21 million in 2025, supported by the country's strong proctology specialty infrastructure, widespread participation in colorectal examinations, and preference for treatments that minimize hospital stays. Japan has a well-established network of dedicated anorectal hospitals and clinics specializing in hemorrhoid management. For example, the Japan Society of Coloproctology continues to support the advancement of specialized anorectal care through clinical education and treatment standardization. Additionally, Japan's aging population and growing demand for quality-of-life-preserving procedures are accelerating adoption of minimally invasive hemorrhoid treatment technologies across specialized healthcare facilities.